HMGB1 and neoplasm: To explore the discrepancies between the two tumor cells, the cell changes induced through MMC treatment were investigated, including cell apoptosis, calreticulin translocation, and high-mobility group box 1 (HMGB1) secretion, to determine why inactivated CMS5 and E.G7 cells conferred distinct tumor protection effects.